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Abstract: The retinal pigment epithelium (RPE) maintains visual function and preserves structural
integrity of the retina. Chronic dysfunction of the RPE is associated with retinal degeneration,
including age-related macular degeneration (AMD). The AMD pathogenesis includes both increased
oxidative stress and complement dysregulation. Physiological sources of oxidative stress in the retina
are well known, while complement sources and regulation are still under debate. Using human
primary RPE (hpRPE) cells, we have established a model to investigate complement component
expression on transcript and protein level in AMD-risk and non-risk hpRPE cells. We evaluated
the effect of properdin, a complement stabilizer, on the hpRPE cell-dependent complement profile
exposed to oxidative stress. hpRPE cells expressed complement components, receptors and regulators.
Complement proteins were also stored and secreted by hpRPE cells. We associated AMD-risk
single nucleotide polymorphisms with an increased secretion of complement factors D (CFD) and I
(CFI). Furthermore, we detected hpRPE cell-associated complement activation products (C3a, C5a)
independent of any extracellularly added complement system. Exogenous properdin increased the
mRNA expression of CFI and CFD, but decreased levels of complement components (C1Q, C3),
receptors (C3AR, C5AR1, CD11B) and inflammation-associated transcripts (NLRP3, IL1B) in hpRPE
cells exposed to oxidative stress. This properdin effect was time-dependently counter regulated. In
conclusion, our data unveiled a local, genotype-associated complement component production in
hpRPE cells, regulated by exogenous properdin. The local complement production and activation via
blood-independent mechanisms can be a new therapeutic target for AMD.
Keywords: retinal pigment epithelium; complement system; properdin; AMD-risk genotype;
intracellular; cell-associated; inflammasome; oxidative stress; human
1. Introduction
As early as 2005, single nucleotide polymorphisms (SNP) in the complement factor H (CFH) gene
were identified as genetic risk factors for age-related macular degeneration (AMD), the major cause of
visual impairment in the Western world [1,2]. Today, it is known that at least eight of these AMD-risk
factors reside in different genes encoding the complement system and enhanced complement deposition
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was observed in AMD-affected eyes [3–6]. However, we still miss a satisfactory answer how these
SNPs or the complement system as a whole contributes to AMD.
The complement system is a pathway of the innate immune system, consisting of over 40 proteins,
which are consecutively activated. Properdin, is the only known stabilizer of the complement system [7].
It binds to the central, activating protein complex of the cascade and prolongs its half-life by 5–10
times. Next to stabilizing the central C3 convertase, properdin has also a potential role as a pattern
recognition molecule activating the complement pathway. The whole complement cascade ensures a
first line defense against pathogens and modified cells producing alarm molecules (anaphylatoxins),
tagging cells/microorganisms (opsonins) or disrupting cell membranes (membrane attack complex) [8].
Additionally, non-canonical intracellular functions of complement components (“the complosome”)
have been described in T-cells, neutrophils, pancreatic β-cells and others [9–11]. Cell-associated or
intracellular complement activity modulated cell metabolism, autophagy, survival, and differentiation
in these different cell types [10,12–14]. However, so far the complement system has not been further
investigated as a cell-dependent/autocrine pathway in relation to AMD so far.
Two major advanced stages of AMD can occur simultaneously in one patient or even in a single
eye: Choroidal neovascularization (CNV) and geographic atrophy (GA) [15,16]. These completely
different disease patterns cause either disruption or loss of the retinal pigment epithelium (RPE).
Besides genetics, clinical data suggested additional external stimuli, for example oxidative stress or
aging processes [17,18], promoting different pathological outcomes in AMD. This needs to be taken
into account investigating the role of complement in RPE and AMD.
The RPE forms the blood–retinal barrier, which separates the retina from the systemic circulation
and the immune system [19]. The RPE acts as a regulatory, secretory epithelium supporting the retina.
It locally secretes complement components as C1q, complement factor B (CFB), complement component
4 (C4), CFI, and CFH [20–23]. We and others showed that complement secretion is modified by external
stress [20–26]. Additionally, generation of complement activation products, such as anaphylatoxins
and opsonins, by healthy and stressed RPE cells independent of any external complement source
is described [21,24,26,27]. Recently, it was reported, that endogenous CFH and anaphylatoxins
contribute to transcriptional and metabolic homeostasis of RPE cells [28–30]. In RPE cells complement
anaphylatoxins receptor signaling is involved in eye morphogenesis [31], sub-RPE deposits [32],
pro-inflammatory RPE reaction [33–35], PI3/Akt-pathway activation [29], and stress-mediated lipid
accumulation in RPE cells [36]. Together this indicates an involvement of autocrine complement
reactivity in housekeeping mechanisms maintaining RPE physiology. However, it is not known in
detail how this is controlled and how it contributes to retinal degeneration.
In the present study, we tested whether human primary RPE (hpRPE) cells produce and activate
complement components in dependence of their genotype and exogenous properdin stress. We
demonstrated that hpRPE cells positive for a homozygous AMD-risk SNP within complement genes
secreted more complement proteins than non-carriers. Thereby, we supposed that the complement
stabilizer properdin modifies the local complement homeostasis in stressed hpRPE cells. We described
that hpRPE cell-dependent complement levels were time-dependently changed by oxidative stress and
properdin addition.
2. Materials and Methods
2.1. Cultivation and Treatment of hpRPE
The research complies with the human research act (HRA) stating that small quantities of bodily
substances removed in the course of transplantation may be anonymized for research purposes
without consent (HRA chapter 5, paragraph 38, Switzerland). hpRPE were prepared from left and
right eyes of 15 anonymized donors (Table 1) as previously described [37,38]. Briefly, hpRPE cells
were harvested from the eyecup after enzymatic digestion and centrifuged with 259× g at 4 ◦C for
5 min. hpRPE cells were cultivated in Dulbecco’s modified Eagle’s medium/Nutrient Mixture F-12
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(DMEM/F 12 GlutaMax, Thermo Fisher Scientific, Dreieich, Germany, #31331-028) containing 5%
fetal bovine serum (FBS, Thermo Fisher Scientific, #10500-064), 1% Penicillin-Streptomycin (Thermo
Fisher Scientific, #15070-063), 1% N1 Medium Supplement (Merck, Darmstadt, Germany, #N6530),
10 mM MEM non-essential amino acids (Thermo Fisher Scientific, #11140-035), 0.25 mg/mL Taurine
(Merck, #T0625), 4.5 mg/mL Glucose solution (Thermo Fisher Scientific, #G524940-01), 0.013 ng/mL
Triiodothyronine (Merck, #T2877), 0.02 µg/mL Hydrocortisone (Merck, #H0888), 20 ng/mL human
basic growth factor (hbFGF, R&D Systems, Minneapolis, MN, USA, #13256029) and 1 mg/mL human
epidermal growth factor (hEGF, Thermo Fisher Scientific, #PHG0311) in laminin-coated Transwell®
inserts under standard conditions (37 ◦C, 5% CO2, 80% humidity).
Table 1. Human primary retinal pigment epithelium (hpRPE) cell genotyping and experimental
assignment in this study.
Used Methods and Results Reference
protein (Fig. 1B)
mRNA (Fig. 1A, 3, 5)
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Accession RPE donors
Gene Number SNP ID 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15
CFH NG_007259 rs121913059 C C C C C C C C C C C C C C
CFH(Y402H) NG_007259 rs1061170 CT T C T C CT T T T CT T CT CT CT
CFH NG_007259 rs570618 GT G GT G T G GT G G G GT G GT GT GT
CFH NG_007259 rs10922109 AC A AC AC C AC AC AC AC A AC C AC AC AC
CFHR3/CFHR1 NG_015993 rs61818925 G GT G G GT G GT G G G G G G G G
C3 NG_009557 rs2230199 C C C C C C C C C C C C CG C C
C3 NG_009557 rs147859257 T T T T T T T T T T T T T T T
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ARMS2 NG_011725 rs3750846 A AG AG A AG A A AG AG A AG AG AG A A
C9 NG_009894 rs6235861 G G G G G G G G G G G G G G G
none AMD-risk heterozygous AMD-risk
Before treatment, FBS concentration was reduced to 0% within 3 days (5%–2.5%–1.25%,
respectively). hpRPE cells were apically treated either with 0.5 mM H2O2, or 0.5 mM H2O2 and
50 µg/mL properdin (Complement Technology, Tyler, TC, USA, #A139) for 4, 10, or 24 h. Supernatants
(apical and basal) were taken before and after treatment, subsequently frozen in liquid nitrogen and
stored at −80 ◦C.
2.2. hpRPE Genotyping
DNA was isolated from sclera slices of the respective donor eyes using ReliaPrep™ FFPE
gDNA Miniprep System (Promega, Mannheim, Germany, #A2351). PCR for amplification of DNA
sequences containing relevant AMD-associated complement SNPs was performed using in-house
generated primers (Table S1) and the following cycle steps, according to the MIQE guidelines [39]:
denaturation (95 ◦C, 1 min), annealing (60 ◦C, 1 min), elongation (72 ◦C, 1 min), 33 cycles. Afterwards,
DNA-sequencing was performed by GeneArt (Thermo Fisher Scientific) using either forward or reverse
in-house primers, respectively (Table S1).
2.3. RT-qPCR and PCR
mRNA was isolated using the NucleoSpin® RNA kit (Macherey-Nagel, Düren, Germany, #740955)
and transcribed into cDNA with the QuantiTect® Reverse Transcription Kit (Qiagen, Hilden, Germany,
Antioxidants 2020, 9, 793 4 of 19
#205313). Transcripts of complement components, regulators, receptors and inflammation-associated
markers were analyzed (i) by PCR (as described in Section 2.2.) and subsequent 2% agarosegel
separation for cDNA fragment visualization, or (ii) by qPCR using Rotor-Gene SYBR® Green PCR
Kit (Qiagen) in a Rotor Gene Q 2plex cycler (Qiagen) either with QuantiTect Primer Assays (Qiagen,
Table S2), or in-house designed primers for IL1B, VIM and SMA1 (Metabion, Planedd, Germany, Table
S1). Data were normalized to the housekeeper GAPDH expression and fold change was calculates
using 2(-Delta Delta C(T)) method [40]. Data are visualized on a linear scale using log2-transformed
scores [41].
2.4. Multiplex Complement Secretion Assay
Complement components in the cellular supernatants after 11–14 days of cultivation were
quantified using the MILLIPLEX MAP Human Complement Panel (Merck, #HCMP1MAG-19K,
#HCMP2MAG-19K) in accordance to the manufacturer’s protocol. The read out of the multiplex assay
was performed in a Magpix instrument (Luminex, Austin, TX, USA).
2.5. Western Blot
Lysates of hpRPE cells were generated using RIPA buffer (Sigma-Aldrich, Munich, Germany,
#R0278) with protease and phosphatase inhibitors (1:100, Sigma-Aldrich, #P8340). Samples were
dissolved in reducing Laemmli sample buffer, denatured (95 ◦C, 10 min) and separated in a 12%
SDS-PAGE and transferred on to an activated PVDF membrane using a wet blotting system. Membranes
were blocked (1 h, 5% bovine serum albumin (BSA)/PBS-T) and incubated with the primary antibodies
(overnight, 5% BSA/PBS-T): Rabbit anti-GAPDH-HRP (1:1000, Cell Signaling Technology, Beverly, MA,
USA, #3683), mouse anti-C3 (1:100, Progen, Heidelberg, Germany, #61019), goat anti-CFI (1:250, Quidel,
San Diego, CA, USA, #A313), mouse anti-C3a (1:50, Hycult, Uden, Netherlands, #HM2074) and mouse
anti-C5a-biotin (1:250, Biozol, Eching, Germany, #BLD-518306). Peroxdiase-conjugated anti-species
antibodies were used for detection (1 h, PBS-T): goat anti-mouse (1:5000, Jackson ImmunoResearch,
West Grove, PA, USA, #115-035-164), rabbit anti-goat (1:5000, Jackson ImmunoResearch, #305-035-003).
Visualization was performed by WesternSure PREMIUM Chemiluminescent Substrate (LI-COR, Bad
Homburg, Germany, #926-95000) in a Fluor Chem FC2 Imaging System (Alpha Innotech, San Leandro,
CA, USA).
2.6. Immunohistochemistry
Immunostaining was performed as described previously [22]. PBS-washed,
paraformaldehyde-fixated (4%, 20 min; Merck, # 100496) hpRPE cells were blocked 3% BSA
(Carl Roth, Karlsruhe, Germany, #8076/ PBS-T, 1 h). Antigens were detected using primary antibodies
anti-RPE65 (1:200; Abcam, Cambridge, UK #ab13826) or anti-bestrophin (1:200; Novus Biologicals,
Littleton, CO, USA #NB300-164), visualized with goat anti-mouse ALEXA Fluor 594 (1:500; Thermo
Fisher Scientific, #A32742) and complemented with nuclei staining (DAPI; Vector Labs, Burlingame,
CA, USA, #H-2000,). Cells were covered with fluorescence mounting medium (Agilent, Boeblingen,
Germany, #S302380-2).
2.7. Statistics
Statistical analysis was performed using GraphPad Prism 7 (GraphPad Software Inc, San Diego,
CA, USA). We estimated a normal Gaussian distribution. Significance levels were determined by
the parametric, unpaired t-test. Welch‘s test was used to correct for unequal sample distribution
variance. All data are expressed as mean ± standard deviation (SD) unless stated otherwise. Detailed
information about specific n-values, implemented statistical tests and coding of significance levels are
provided in the respective figures and figure legends.
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3. Results
RPE cells are capable of producing cell-derived complement components as we showed
recently [22,42]. In the present study we assume that an externally added complement regulator,
properdin, can modulate stress-dependent RPE cell-derived complement components.
3.1. Human Primary RPE Cells as a Model System in Cell Culture
We investigated human primary RPE (hpRPE) cells, isolated and cultivated from 15 different
donor eyes (Table 1). Studied hpRPE cells were vital and pigmented as well as positive for the RPE
markers RPE65 and bestrophin (Figure S1A–G). Pigmentation of the hpRPE cells was stable from 4 to
14 days of cultivation (after removal of non-adherent cells at day 2).
Ex vivo cultivation of hpRPE of both eyes resulted in a maximum of 6 transwell filters with a
growth area of 1.12 cm2 from each donor. This limited the study and not all investigations could be
performed with the hpRPE cells from the same donor. An overview of the used cell preparations and
experiments is given in Table 1.
3.2. hpRPE Cells Produce Complement Components
All tested hpRPE cells were positive for transcripts of complement components C1Q, C3, C4A,
C4B, C5, CFB, and CFD, as well as complement regulators CFI, CFH, properdin (CFP), CD46, and CD59
(Figure 1A). hpRPE cells expressed also complement receptors for complement activation products like
the anaphylatoxin receptors C3AR and C5AR1 as well as the subunit CD11B of complement receptor 3,
which interacts with the C3 cleavage products (iC3b, C3d, C3dg) upon activation (Figure 1A).
hpRPE cells produced complement proteins as C3 and CFI shown by Western blot (Figure 1B).
This raised the question, if complement receptors of hpRPE cells could be modulated in an autocrine
signaling pathway if complement activation products are generated by these cells. Analyzing hpRPE
cell lysates in Western blot, we found hpRPE cell-derived complement activation products C3a, C5a
and further C3 cleavage products (C3d, C3dg) in untreated hpRPE cells independent from any external
complement sources, indicating a possible autocrine cleavage and function of hpRPE cell-derived
activated complement components (Figure 1B and Figure S2 ).
We also determined secreted complement components in the cell culture supernatants of hpRPE
preparations from both eyes 11–14 days after isolation (Figure 1C). Thereby, we detected C3, C3b, C4,
CFB, CFD and the regulators CFI as well as CFH in the supernatants (Figure 1C). C1q, C5 and the
complement activation products C4b and C5a were either not secreted or below the assay detection
limits (Figure 1C). We also identified differences of complement secretion levels between hpRPE
cell preparations of the left and right eye (Figure S3). However, we cannot judge the influence of
retinal phenotype and cell preparation differences. Apical and basal complement secretion levels were
comparable (Figure S3), but due to low cell numbers and reduced cell division of hpRPE a confluent
monolayer was not always observable. Furthermore, we cannot exclude passive diffusion of the
complement components secreted apically and basally through the membrane filter (Figure S3).
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blots are depicted in (B) for donor 5 (C5a) and donor 6 (C3, C3a, CFI). (C) hpRPE cells secrete C3, C4, 
CFB, CFD and the regulators CFI as well as CFH into the cell culture supernatant (pooled data of two 
eyes, apical and basal supernatant are shown, details for hpRPE cells of donors 11–16 are presented 
in Figure S3). Mean with standard deviation is shown. Dotted line depicts blank control. MFI—mean 
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homozygous AMD-risk SNPs SNP (donors 12, 13, 15) and non-homozygous AMD-risk SNP hpRPE 
cells (donors 10, 11, 14) (Table 1, Figure 2). Thereby, significantly higher CFD and CFI levels in 
supernatants of hpRPE cells with the AMD-associated risk SNPs in complement genes were found 
(Figure 2A,B). A comparable tendency was also observed for complement regulators CFH and the 
central complement component C3, which were increased in supernatants of hpRPE with the AMD-
risk genotypes after 14 days of cultivation compared to non-risk cells (Figure 2C,D). Only the 
secretion of components of the alternative pathway was affected by AMD-risk SNPs in complement 
genes under the described experimental conditions. However, we cannot definitely state that the 
Figure 1. hpRPE cells express and secrete comple ents. (A) mRNA expression of main
complement components of the clas ical ( 1 ) cla sical/lectin (C4A, C4B), terminal (C5)
and alternative (CFB, CFD) complement path ay as etecte in hpRPE cells. hpRPE cells expressed
also mRNA of soluble (CFI, CFH, CFP) and membrane bound (CD46, CD59) complement regulators,
and transcripts of complement receptors: anaphylatoxin receptors (C3AR, C5AR1), opsonin receptor
CR3 subunit (CD11B). Shown expression data of donor 1 are representative for mRNA experiments in
hpRPE cells of donors 1–4 (Table 1). (B) Activation products of the central complement component C3
[(blot left, arrows) C3b (115 kDa), C3dg (39 kDa) and C3d (35 kDa)] were detected in hpRPE. Multiple
bands were identified in hpRPE cells using an anti-complement regulator CFI antibody (blot center,
arrows for full CFI (80 kDa) and two CFI disulfide linked chains (50 kDa, 30 kDa)). Anaphylatoxins C3a
and C5a (blot r ght) were found in cell lysates of hpRPE cells. Examples of whole b ot a depicted in
(B) for donor 5 (C5a) and donor 6 (C3, C3a, CFI). (C) hpRPE cells secrete C3, C4, CFB, CFD and the
regulators CFI as well as CFH into the cell culture supernatant (pooled data of two eyes, apical and
basal supernatant are shown, details for hpRPE cells of donors 11–16 are presented in Figure S3). Mean
with standard deviation is shown. Dotted line depicts blank control. MFI—mean fluorescence intensity.
3.3. AMD-Risk SNPs in Complement Genes Increase hpRPE Cell-Dependent Complement Secretion
SNPs within genes of the complement cascade were previously associated with the risk of retinal
degeneration and changed retinal/RPE physiology [4,43,44]. We analyzed 13 complement-associated
risk SNPs in the donor tissues to evaluate the effect of these SNPs on hpRPE cell-derived complement
secretion. We found 4 of 15 donors positive for 1–3 homozygous AMD-risk SNPs either in the CFH,
C2/CFB or CFI gene loci and all donors were positive for 1–5 heterozygous AMD-risk SNPs (Table 1).
Furthermore, we compared complement secretion levels of hpRPE cells positive for at least one
homozygous AMD-risk SNPs SNP (donors 12, 13, 15) and non-homozygous AMD-risk SNP hpRPE
cells (donors 10, 11, 14) (Table 1, Figure 2). Thereby, significantly higher CFD and CFI levels in
supernatants of hpRPE cells with the AMD-associated risk SNPs in complement genes were found
(Figure 2A,B). A comparable tendency was also observed for complement regulators CFH and the
central complement component C3, which were increased in supernatants of hpRPE with the AMD-risk
genotypes after 14 days of cultivatio com red to non-risk cells (Figure 2C,D). Only the s cr tion
of components of th alternativ pathway was affected by AMD-risk SNPs complement genes
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under the described experimental conditions. However, we cannot definitely state that the hpRPE
culture always resulted in the same cell numbers on the transwell filters investigated (even the same
preparation protocol was used).
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Figure 2. Secretion of alternative complement pathway components was increased in hpRPE
cells positive for homozygous age-related macular degeneration (AMD)-risk single nucleotide
polymorphisms (SNPs) (risk; donors 12, 13, 15). Significant higher levels of secreted (A) complement
factors D (CFD), (B) complement factors I (CFI) and in tendency higher (C) complement factor H (CFH)
and (D) C3 secretion levels were detected in apical (black) and basal (grey) supernatants of hpRPE
cells with homozygous A -risk S Ps (risk; donors 12, 13, 15) compared to hpRPE cells without
a homozygous AMD-risk SNP (none; donors 10, 11, 14) in complement genes (Table 1). Mean with
standard deviatio is shown. * p < 0.05, ** p < 0.01 unpaired t-test with Welch‘s correction. Dotted line
depicts blank control. MFI—mean fluorescence intensity.
3.4. Complement Regulator Properdin Increased Expression of Complement Proteases in Stressed hpRPE Cells
We showed rec ntly that oxidative stress i cr s t ression of complement regulator
properdin in RPE cells [22]. In the pres , estigated the effect of externally ad ed
properdin on stressed hpRPE cells. hpRPE cel s ere tr t it 2O2 alone or with combined
H2O2 and properdin. Transcri l r ithelial–mesenchymal transition (EMT),
complement components, regulators and rece t ared betw en these treatment groups
(Figure 3 and Figure S1). After 4 h of properdin treatment, hpRPE cells showed a te dency of
increased EMT markers (Figure S1). Simultaneously, transcripts for complement proteases CFD and
CFI were significantly upregulated in hpRPE cells (Figure 3A), while other complement components,
which are involved in the general complement cascade (C1Q, C3), and complement receptors (C3AR,
C5AR1, CD11B) were downregulated (Figure 3A). This effect slightly differed in the four tested hpRPE
preparations of donors 1–4 pooled in herein, but a genotype-dependent reaction was not observable
due to limitations of the cohort size. All tested hpRPE preparations were negative for a homozygous
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AMD-risk SNP within complement genes (Table 1). Properdin treatment of stressed cells did not
change the expression levels of C4, CD59, CD46, and CFP (data not shown).
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Figure 3. Complement regulator properdin changed complement mRNA expression in stressed hpRPE
cells. (A) H2O2 stressed hpRPE cells were treated with properdin (CFP) for 4 h. mRNA expression
of main complement components C1Q, C3, C5, and CFB (black) as well as complement receptors
C3AR, C5AR1, and CD11B (grey) was decreased in comparison to stressed cells (dotted line). CFD
(black) and complement regulators CFI and CFH (white) mRNA expression was increased in stressed,
properdin-treated cells compared to stressed cells only. Data from onors 1–4 are presented. Mean
with andard deviation is shown. * p < 0.05, ** p < 0.01 unpaired t-test with Welch‘s c rection of
stressed versus stresse , pr perdin-treated cells. (B) H2O2 stressed hpRPE cells of donor 1 wer tr a ed
with properdin for 4 h (dark blue) or 24 h (light blue). mRNA Expression of complement components
and receptors was reversed after 24 h compared to 4 h. Mean with standard deviation is shown. * p <
0.05, ** p < 0.01 unpaired t-test with Welch‘s correction of 4 h versus 24 h properdin treatment.
hpRPE cells of donor 1 were used to compare the early (4 h) and late (24 h) effect of external
properdin on transcription levels (Figure 3B). We found time-dependent differences of complement
expression in properdin-treated cells for all investigated transcripts. Transcription tendencies detected
after 4 h were always reversed after 24 h. For example, complement proteases CFD and CFI were
decreased and mRNA of complement receptors C3AR, C5AR1, and CD11B were increased after 24 h
(Figure 3B).
In summary, our expression data suggested an early anti-inflammatory and a late pro-inflammatory
transcriptional response of stressed hpRPE cells upon properdin treatment.
Consistent with the transcription results secretion of complement components CFD, CFI, and
CFH was time-dependently changed in stressed, properdin-treated hpRPE cells compared to stressed
cells (Figure 4). CFD levels in the apical supernatant were increased 4 h after properdin treatment
and declined over time. This was in accordance with the mRNA transcription analyses (Figure 3). In
contrast to the transcription results, where we described an early increase of CFI and CFH mRNA,
the protein levels of CFI and CFH were rather reduced in the supernatant of properdin-treated
hpRPE cells (Figure 4). This suggested an intracellular accumulation of these proteins following
properdin interaction as described previously for stressed ARPE-19 cells [22]. C4 and CFB secretion
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was not significantly changed by properdin addition (Figure 4). C3 secretion could not be reliably
determined, as the added properdin resulted in unspecific signals in the used commercial multiplex
complement assay.
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inflammasome-associated mRNA expression in stressed RPE cells, we investigated NLRP3 and IL1Β 
transcripts in properdin-treated and non-treated stressed hpRPE cells (Figure 5). NLRP3 and IL1Β 
expression was decreased after 4 h in properdin-treated cells compared to only H2O2-stressed cells 
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Figure 4. Complement protein secretion was odulated in stressed hpRPE cells by properdin.
Complement protein secretion into the apical supernatant 4 h (white), 10 h (grey) and 24 h (black)
after properdin treatment of H2O2 stressed hpRPE is shown as percentage of the secretion level of
stressed, non-properdin treated cells (dotted line). We observed a time-dependent change in CFD levels
(significantly increased after 4 h) in apical supernatants of stressed properdin-treated hpRPE cells.
Decreased concentrations of complement regulators CFI and CFH were detected after 4 h of properdin
treatment. Shown are data of donors 2, 4, and 8 for 4 h; donors 3, 5, and 6 for 10 h; donor 1 for 24 h.
Mean with standard deviation is shown. * p < 0.05, ** p < 0.01 t-test with Welch‘s correction of stressed
hpRPE versus stressed, properdin-treated hpRPE.
3.5. Inflammasome-Associated Transcription Levels were Reduced by Properdin in Stressed hpRPE Cells
Recently, we showed an increase of inflammasome activation following oxidative stress in
ARPE-19 cells [22]. To answer the question how the complement regulator properdin acts on
inflammasome-associated mRNA expression in stressed RPE cells, we investigated NLRP3 and IL1B
transcripts in properdin-treated and non-treated stressed hpRPE cells (Figure 5). NLRP3 and IL1B
expression was decreased after 4 h in properdin-treated cells compared to only H2O2-stressed cells
(Figure 5B). This confirmed the suggested early anti-inflammatory effect of properdin on H2O2-stressed
hpRPE cells (Figure 3A). After 24 h NLRP3 transcripts were still reduced, but IL1B were counter
regulated in comparison to 4 h with increased IL1B levels (Figure 5C).
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RPE are: (i) Absorption of light and protection against photo-oxidation, (ii) secretion of immune 
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These activities can be altered under non-physiological conditions. In this study, we used hpRPE cells 
from human donors in order to assure as much in vivo-like RPE cell characteristics as possible in our 
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Figure 5. Inflammaso e-associated R A transcripts were differentially expressed in stressed,
properdin-treated hpRPE cells. (A) Inflammasome NLRP3 and pro-inflammatory cytokine IL1B
mRNA was detected in hpRPE cells. Shown expression data of donor 1 are representative for mRNA
experiments in hpRPE cells of donors 1–4 (Table 1). (B) Properdin treatment of H2O2-stressed hpRPE
cells showed a significant reduced expression of NLRP3 and IL1B after 4 h. Data from donors 1–4 are
presented. (C) H2O2-stressed hpRPE cells of donor 1 were treated with properdin for 4 h (dark blue) or
24 h (light blue). Reduc d NLRP3 mRNA expr ssi n was acc lerated over time and IL1B transcripts
wer significantly i creased after 24 h compared to 4 h properdin incubation. Mean with standard
deviation is shown. * p < 0.05, ** p < 0.01 unpaired t-test with Welch‘s correction of 4 h versus 24 h
properdin treatment.
4. Discussion
AMD is ultifactorial pathological process in the retina resulting from alteratio of the RPE.
Chronic inflammator changes in the RPE ca ead to blood–retinal barrier breakdown and dis ase
progression. Thereby, th inn e immu ity including the complement system plays a pivotal role. Our
study demonstrated that compon nts of the complement syste , a part of the innate immune system
are produced and secreted by RPE cells. The local complement quantity and activity was modulated
by external stress affecting the RPE and contributing to a disturbed blood–retinal barrier.
4.1. Biological Relevance of hpRPE In Vitro Experiments
RPE cells are differentiated and polarized cells, which for a monolayer and are part of the
blood–retinal barrier between the photoreceptors and Bruch’s membrane. The main functions of
the RPE are: (i) Absorption of light and protection against photo-oxidation, (ii) secretion of immune
modulators and growth factors as well as (iii) phagocytosis and recycling of shed photoreceptor [19].
These activities can be altered under non-physiological conditions. In this study, we used hpRPE cells
from human donors in order to assure as much in vivo-like RPE cell characteristics as possible in our
in vitro experiments. Different genotypes, environmental influences and in vivo differentiation had an
impact on the variability and biological relevance of our results. We investigated hpRPE cells from
the right and the left eye of 15 different donors, which reflected the RPE phenotype in the human
eye [45]. This attached high importance to our results compared to results obtained from immortal,
Antioxidants 2020, 9, 793 11 of 19
manipulated cell lines [46–48] (RPE in vitro systems were excellently reviewed in [19]). Optimal
culture conditions resulted in physiological cell morphology and pigmentation of the ex vivo supplied
cells [45]. Pigmentation of the RPE cells was a marker for differentiation, not often detected in cultured
human RPE cell lines [49].
4.2. hpRPE as a Source for Complement Components in the Eye
Previous work identified the RPE as one of the major sources of complement transcripts in the
mouse retina [42,50]. Here, we presented for the first time a comprehensive description of transcribed
complement components (C1Q, C3, C4, C5, CFB, CFD), regulators (CFI, CFH, CFP, CD46, CD59) and
receptors (C3AR, C5AR1, CD11B) in cultivated hpRPE cells. In accordance with our results C3, CFH,
and complement receptor C5AR have already been shown to be expressed in the immortalized retinal
pigment epithelial cell line ARPE-19 and in primary RPE cells [22,35,51]. RPE cells derived from
induced pluripotent stem cells (iPSC) express mRNA for complement activators C3, C5, CFB, and
complement inhibitors CFH, CFI, CD46, CD55, CD59, CLUSTERIN, and VITRONECTIN [23]. Single cell
transcriptomic analysis in human organoids also showed CFH, C3, and C2 expression in RPE cells [52].
Similar to hpRPE, non-liver dependent complement gene expression was also described for
intestinal epithelial cells, podocytes and other cell types [42,53,54].
In addition to complement transcripts, we also detected complement components C3, C3b, C4,
CFB, CFD as well as complement regulators CFI and CFH in supernatants of hpRPE cells independent
of any external complement sources. This was in line with previously published data for post-confluent
ARPE-19 cells which secreted C3, C3a, C4bp, CFI, and CFH [20–22] and iPSC-derived RPE cells
that secreted CFB [23,26]. C3 was previously also found in supernatants of primary mouse RPE
cells [50]. Therewith, our and other results suggest a local RPE cell-dependent source of the complement
components independent from liver-derived complement proteins in the eye.
hpRPE cell-dependent complement secretion was regulated by environmental, external stimuli.
We documented variable complement levels in supernatants comparing secretion of left and right eye
hpRPE of the same donor. In contrast to inherited eye diseases, where often both eyes are affected
to a similar extent, acquired vision loss can occur in different degrees in the left and right eye. For
AMD it is known that the disease progression can be dissimilar between both eyes [55,56]. Our
data support this monocular specific disease progression also on the level of hpRPE cell-dependent
complement secretion.
4.3. AMD-Risk SNPs in Complement Genes Enhanced hpRPE Cell-Dependent Complement Secretion
RPE dysfunction in AMD is associated with SNPs in complement system genes. An international
AMD-genome wide association study listed six complement gene loci as top priority AMD-relevant
risk candidates based on biological and statistical evidence [4,57,58]. Nevertheless, detailed studies of
how precisely certain AMD-risk genotypes modify complement function and protein expression are
still lacking.
Here, we found that these SNPs within the complement genes modulate local complement secretion.
hpRPE obtained from donors positive for at least one homozygous complement risk SNP secreted
higher levels of complement components than hpRPE cells heterozygous for the complement-associated
AMD-risk SNPs. The increase was significant for alternative complement pathway components CFD/
CFI and a tendency was observed for CFH/C3. Related research showed that AMD-risk SNP enhances
complement activity in the RPE and the retina. Higher levels of C5a in Bruch’s membrane and increased
membrane attack complex deposition in eyes homozygous for the high-risk CFH genotype Y402H
were identified [43,44]. Complement dysregulation was also described for a homozygous risk-SNP in
the ARMS2 gene [59]. In contrast, blood-derived CFI was reduced in AMD patients with a CFI SNP
compared to patients without the SNP [60].
At least two mechanistic models are possible how genetic polymorphism in genes of the
complement system could modify the ability of hpRPE cells to secrete components: (i) Polymorphism
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within a gene or in a regulatory region near a gene itself could results in gain- or loss-of
transcription/secretion/function of the affected complement component. This is already known
for SNPs in C3 [61,62]. (ii) Autocrine regulation of complement transcripts/secretion by complement
complexes or cleavage products, which are only produced if the SNP is present, could be imaginable.
Complement components or complement cleavage products can activate cellular signaling pathways
via specific receptors [63–65], which can result in increased or reduced transcription of complement
components by associated transcription factors [66–68]. As we showed the secretion of complement
components and presents of complement activation products as well as of receptors in hpRPE cells an
autocrine regulation of complement is speculatively possible.
In sum, polymorphisms within complement genes can cause different effects in AMD patients,
locally in the retina and systemically.
4.4. hpRPE Cell-Dependent Complement Activation
Complement components can act as signal molecules by binding to their cellular receptors [8,11]. A
pivotal requirement for complement activation is the cleavage of complement components, e.g., C3/C5,
into their active, receptor-binding fragments. This can be carried out either by enzyme complexes formed
by different complement proteins (convertases) or by specific proteases, e.g., cathepsin L or cathepsin
B [11,69]. This results in high levels of anaphylatoxins C3a and C5a, which have been associated with
physiological and pathological processes in the retina [27,70,71]: Eye morphogenesis [31], sub-RPE
depositions [32], pro-inflammatory RPE reaction [33–35], PI3/Akt-pathway activation [29], and ER
stress-mediated lipid accumulation [36].
Interestingly, we detected complement activation end products C3a and C5a in untreated hpRPE
cells independently of the entire complement cascade. In addition, further C3 cleavage products
C3d and C3dg were found cell-associated. Considering the absence of any external complement
source, these findings indicate that complement activation occurred intracellularly, originating from
autonomously produced complement protein. The production of C3a and C5a has previously been
described by other groups [21,26], who detected the anaphylatoxins in RPE cells following nitration of
the extracellular matrix or administration of amyloid β, respectively. Activated C3b was additionally
described in deposits of human fetal RPE cells cultivated without serum, indicating that a local RPE
cell-associated cleavage of C3 may be efficient to excite early stages of AMD [24].
Intracellular activation of C3 has been assumed to be a general phenomenon, being observed in
various cell types, including epithelial cell lines and murine RPE cells [11,27]. Autocrine effects of
complement have initially been described in T-cells, where these processes were important to maintain
the cell homeostasis [11,72]. Similar signaling also plays a major role in the tumor microenvironment,
where it promotes tumor growth [70,73]. We previously suggested an autocrine function of complement
components in ARPE-19 cells exposed to oxidative stress showing a colocalization of C3 and complement
receptor 3 (CR3) [22]. Since hpRPE cells do also express the corresponding complement receptors for
the autonomously produced complement activation proteins, it can be assumed that hpRPE cell can be
regulated by autocrine complement-associated mechanisms, which needs to be further investigated.
4.5. Oxidative Stress and Properdin Altered Complement and Inflammasome Associated Expression in
hpRPE Cells
AMD progresses by an interplay of genetics and cellular stress, triggered for example by oxidative
stimuli [74]. We showed recently that H2O2 exposure of RPE cells resulted in increased levels of RPE
cell-derived complement regulator properdin [22]. Properdin is the only known positive regulator of
the complement system that stabilizes the C3-convertase [75,76]. Here we answered the question, how
exogenous properdin can further influence the complement homeostasis of stressed hpRPE cells.
Notably, properdin treatment of stressed hpRPE cells resulted in an upregulation of CFD and CFI
transcript levels, which could modulate the immune homeostasis in the retina: CFD and CFI are both
proteases of the complement pathway. CFD cleaves Factor B and activates the alternative pathway,
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while CFI inactivates C3b as well as C4b [8]. In accordance with transcription data, we found also
increased CFD protein concentrations in supernatants of hpRPE cells 4 h after properdin treatment.
However, the levels of secreted CFI were decreased after properdin treatment, which was contradictory
compared to the CFI mRNA levels and suggested an intracellular storage of CFI mRNA or protein in
properdin-treated hpRPE cells. Intracellular storage of complement components in epithelial cells was
previously associated with protection against cell death mechanisms [77].
Opposing to an upregulation of CFI and CFD mRNA expression after properdin treatment, we
detected a reduction of complement transcripts C1Q and C3 as well as complement receptors C3AR,
C5AR1 and CD11B. Interestingly, C3 expression was shown to be upregulated in oxidatively stressed
iPSC-derived RPE and ARPE-19 cells [36,78] and previous work of our group demonstrated C5AR1 and
CD11B upregulation in oxidatively stressed ARPE-19 cells [22]. This suggested a properdin-mediated
contra regulation of complement transcription in oxidatively stressed hpRPE cells.
In line with this, we found a reconstitutional effect of properdin treatment in stressed hpRPE
cells associated with inflammasome-linked transcripts. There are different opinions about the role of
NLRP3 inflammasome in RPE cells homeostasis [79,80], but certainly NLRP3 has a pro-inflammatory
effect. In line with that, there is an upregulation of NLRP3 and IL1B mRNA in oxidative stressed RPE
cells, as we and others described in the past [22,81]. The additional exogenous properdin caused a
NLRP3 and IL1B mRNA reduction after 4 h. This suggested a time-dependent regulative mechanism
with an early anti-inflammatory effect of properdin.
4.6. Time-Dependent Shift in Complement Gene Expression Levels Following Properdin Treatment of
Stressed hpRPE
When treating H2O2-stressed hpRPE with exogenous properdin, early complement component
mRNA expression differed from late expression. Similarly, we showed earlier that oxidative stress
conditions in mouse RPE lead also to a time-dependent regulation of complement component
expression [82].
Of note, in our present study transcription levels of properdin-treated cells were always reversed
after 24 h compared to 4 h. Our assumption of a tightly regulated time-dependent complement
expression profile in the RPE and retina was further supported by others showing that complement
inhibiting components peaked simultaneously with photoreceptor apoptosis after light-induced retinal
damage in rats [83]. A similar effect was observed for expression of AMD-related genes and cytokines
in mice after intravenous sodium iodate injection [84].
Our data indicate a time-dependent early anti-inflammatory and late pro-inflammatory response
of stressed hpRPE following properdin treatment. Our findings suggest that hpRPE cells are capable to
autonomously counter regulate the effects of properdin exposure. All transcript analyses in this study
were performed on hpRPE cells without an AMD-associated SNP within complement genes (donors
1–4) which suggested that healthy cells can circumvent external properdin stress. However, it is not
yet known, how RPE cells that are positive for a SNP within complement genes can handle properdin
stress, maybe counter regulation is not possible or exuberant. This needs to be further investigated in
the future.
In the meanwhile clinical studies already indicate a potent impact of anti-Properdin antibodies
in AMD patients: Intravitreal injection of 10 mg anti-Properdin antibodies reduced the lesion size in
GA patients by ~16% compared to sham treated patients in phase 2 studies (not yet significant,
NCT02515942). It seems to be a dose dependent reaction as a combination therapy of 5 mg
anti-properdin and 5 mg anti-C5 antibodies failed to reduce lesion extension compared to the
sham group (NCT02515942). However, irrespective if an anti-properdin antibody shows an effect on
AMD progression in the present study, anti-properdin therapies offer the great advantage that they
do not completely block the complement pathway, but instead slow down this pivotal cascade by
retaining the balance of the local complement system.
Antioxidants 2020, 9, 793 14 of 19
5. Conclusions
Our results suggested that SNPs within the complement system may contribute to RPE
cell-dependent local complement production in the human eye. Complement activation observed at the
RPE cell layer did not rely on systemic complement components but could be modulated by external
stimuli. Properdin, the only known positive regulator of the complement system, ameliorated the effects
of oxidative stress-induced complement expression in early phases and increased pro-inflammatory
markers in late treatment phases.
In view of the limited sample size of hpRPE cells in this study, further studies with larger cohorts
from different human donor eyes are warranted to confirm the role of genotype-dependent complement
production of RPE cells. Further work is also needed to distinguish the exact role of intracellular or
cell-associated and blood-derived complement as well as complement activation in the retina/RPE in
the development of chronic inflammatory retinal diseases such as AMD.
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